137 related articles for article (PubMed ID: 1087592)
1. Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.
Bjune G; Barnetson RS
Clin Exp Immunol; 1976 Dec; 26(3):397-402. PubMed ID: 1087592
[TBL] [Abstract][Full Text] [Related]
2. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.
Bjune G; Barnetson RS; Ridley DS; Kronvall G
Clin Exp Immunol; 1976 Jul; 25(1):85-94. PubMed ID: 791549
[TBL] [Abstract][Full Text] [Related]
4. Studies on T cell subsets and functions in leprosy.
Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
6. Phytohaemagglutinin (PHA)-induced transformation of peripheral blood-lymphocytes in leprosy patients.
Ghei SK; Sengupta U; Ramu G
Lepr India; 1980 Apr; 52(2):223-8. PubMed ID: 6969819
[TBL] [Abstract][Full Text] [Related]
7. In vitro modulation of lymphocyte responses to phytohaemagglutinin by plasma in mother and baby at the time of birth. Increased lymphocyte responses in babies of mothers with lepromatous leprosy.
Bjune G; Duncan E; Barnetson RS; Melsom R
Clin Exp Immunol; 1978 Jun; 32(3):517-22. PubMed ID: 308425
[TBL] [Abstract][Full Text] [Related]
8. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
Sengupta U; Sinha S; Ramu G; Lamb J; Ivanyi J
Clin Exp Immunol; 1987 Apr; 68(1):58-64. PubMed ID: 3308210
[TBL] [Abstract][Full Text] [Related]
9. Cellular immunity in patients with leprosy. Circulating T lymphocytes and their response to PHA in leprosy.
Kaklamanis E; Drouga M; Kouzoutzakoglou K; Karalis D; Trichopoulos D
Int J Lepr Other Mycobact Dis; 1977; 45(3):241-7. PubMed ID: 303622
[TBL] [Abstract][Full Text] [Related]
10. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
12. Cell changes and soluble interleukin-2 receptors (Tac peptide) in leprosy reversal reactions using suction-induced blisters.
Theetranont C; Bhoopat L; Scollard DM
J Med Assoc Thai; 1990 Apr; 73(4):181-90. PubMed ID: 2394954
[TBL] [Abstract][Full Text] [Related]
13. Serum lymphocytotoxic activity in leprosy.
Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
[TBL] [Abstract][Full Text] [Related]
14. Studies of human leprosy lesions in situ using suction-induced blisters. 2. Cell changes and soluble interleukin 2 receptor (Tac peptide) in reversal reactions.
Scollard DM; Suriyanon V; Bhoopat L; Wagner DK; Smith TC; Thamprasert K; Nelson DL; Theetranont C
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):469-79. PubMed ID: 1976132
[TBL] [Abstract][Full Text] [Related]
15. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
16. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
Silva C; Lima AO; Andrade LM; Mattos O
Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
[TBL] [Abstract][Full Text] [Related]
17. Status of circulating "T" lymphocyte population in leprosy.
Sachdev KN; Mathur DR; Chawla SN
Lepr India; 1980 Jul; 52(3):383-9. PubMed ID: 6970855
[TBL] [Abstract][Full Text] [Related]
18. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST CMI.
Walsh DS; Villahermosa LG; Balagon MV; Abalos RM; Fajardo TT; Tan EV; Cellona RV; Walsh GP
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):518-26. PubMed ID: 10774662
[TBL] [Abstract][Full Text] [Related]
20. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
